Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Infection and Chemotherapy ; : 164-168, 2006.
Artigo em Inglês | WPRIM | ID: wpr-721474

RESUMO

Non-albicans Candida species which are resistant to azole are emerging as important pathogens in patients with hematological malignancies who received antifungal prophylaxis. C. inconspicua is one of rare Candida spp. and resistant to fluconazole and deep infection due to C. inconspicua has not been reported in Korea so far. We reported here two cases of candidemia due to C. inconspicua in neutropenic patients with acute leukemia. C. inconspicua were presumed to be originated from gastrointestinal tract in both cases. The antifungal susceptibility test of C. inconspicua in case 1 showed resistance to fluconazole and itraconazole. Both cases were successfully treated by amphotericin B deoxycholate. Clinicians should keep in mind that non-albicans Candida species would be emerging pathogen in immunocompromised hosts and early recognition and appropriate use of antifungal agents is necessary.


Assuntos
Humanos , Anfotericina B , Antifúngicos , Candida , Candidemia , Danazol , Ácido Desoxicólico , Fluconazol , Fungemia , Trato Gastrointestinal , Neoplasias Hematológicas , Hospedeiro Imunocomprometido , Itraconazol , Coreia (Geográfico) , Leucemia , Neutropenia
2.
Infection and Chemotherapy ; : 164-168, 2006.
Artigo em Inglês | WPRIM | ID: wpr-721979

RESUMO

Non-albicans Candida species which are resistant to azole are emerging as important pathogens in patients with hematological malignancies who received antifungal prophylaxis. C. inconspicua is one of rare Candida spp. and resistant to fluconazole and deep infection due to C. inconspicua has not been reported in Korea so far. We reported here two cases of candidemia due to C. inconspicua in neutropenic patients with acute leukemia. C. inconspicua were presumed to be originated from gastrointestinal tract in both cases. The antifungal susceptibility test of C. inconspicua in case 1 showed resistance to fluconazole and itraconazole. Both cases were successfully treated by amphotericin B deoxycholate. Clinicians should keep in mind that non-albicans Candida species would be emerging pathogen in immunocompromised hosts and early recognition and appropriate use of antifungal agents is necessary.


Assuntos
Humanos , Anfotericina B , Antifúngicos , Candida , Candidemia , Danazol , Ácido Desoxicólico , Fluconazol , Fungemia , Trato Gastrointestinal , Neoplasias Hematológicas , Hospedeiro Imunocomprometido , Itraconazol , Coreia (Geográfico) , Leucemia , Neutropenia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA